Literature DB >> 14102034

MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

G CANETTI, S FROMAN, J GROSSET, P HAUDUROY, M LANGEROVA, H T MAHLER, G MEISSNER, D A MITCHISON, L SULA.   

Abstract

In its seventh report, published in 1960, the WHO Expert Committee on Tuberculosis "noted the need for international standards for the definition and determination of drug resistance which will permit comparisons to be made from one area to another, and recommended that the World Health Organization take appropriate steps to establish such standards".(10) Acting on this recommendation, WHO took the first step towards standardization by convening in Geneva, in December 1961, an informal international meeting of specialists in the bacteriology of tuberculosis. At this meeting an attempt was made to formulate prerequisites for reliable sensitivity tests and to specify the technical procedures for them.The first part of the present paper is a joint contribution by the participants in the meeting, summarizing the general conclusions reached and recommendations made with regard to tests of sensitivity to the three main antituberculosis drugs-isoniazid, streptomycin and p-aminosalicylic acid. The other three parts describe, in turn, three different tests for determining drug sensitivity-the absolute-concentration method, the resistance-ratio method and the proportion method-that are generally considered to give reasonably accurate results.

Entities:  

Keywords:  AMINOSALICYLIC ACID; DRUG RESISTANCE, MICROBIAL; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; PHARMACOLOGY; STREPTOMYCIN

Mesh:

Substances:

Year:  1963        PMID: 14102034      PMCID: PMC2555065     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  155 in total

1.  Optimization of a nucleic acid-based reporter system to detect Mycobacterium tuberculosis antibiotic sensitivity.

Authors:  Matthew C Mulvey; Margaret Lemmon; Stephanie Rotter; Jonathan Lees; Leo Einck; Carol A Nacy
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

Review 2.  An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future.

Authors:  Jotam Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

3.  Performance of tuberculosis drug susceptibility testing in U.S. laboratories from 1994 to 2008.

Authors:  Pawan K Angra; Thomas H Taylor; Michael F Iademarco; Beverly Metchock; J Rex Astles; John C Ridderhof
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

4.  In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex.

Authors:  S Naik; R Ruck
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

5.  Rapid genotypic detection of rpoB and katG gene mutations in Mycobacterium tuberculosis clinical isolates from Northern India as determined by MAS-PCR.

Authors:  Anamika Gupta; Pradyot Prakash; Surya K Singh; Shampa Anupurba
Journal:  J Clin Lab Anal       Date:  2013-01       Impact factor: 2.352

6.  Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis.

Authors:  Juan-Carlos Palomino; Anandi Martin; Mirtha Camacho; Humberto Guerra; Jean Swings; Françoise Portaels
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 7.  Tuberculosis: drug resistance, fitness, and strategies for global control.

Authors:  Erik C Böttger; Burkhard Springer
Journal:  Eur J Pediatr       Date:  2007-11-07       Impact factor: 3.183

8.  Safe determination of susceptibility of Mycobacterium tuberculosis to antimycobacterial agents by flow cytometry.

Authors:  A V Moore; S M Kirk; S M Callister; G H Mazurek; R F Schell
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry.

Authors:  M A Norden; T A Kurzynski; S E Bownds; S M Callister; R F Schell
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

10.  New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability.

Authors:  Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.